Work with All.Can as its new CEO

All.Can International is currently looking to recruit a Chief Executive Officer (CEO) to lead the initiative into an exciting new phase.

Latest news

All.Can at the World Summit of Brain Tumour Patient Advocates

At the 4th Biennial World Summit of Brain Tumour Patient Advocates Suzanne Wait, shared findings from the All.Can patient survey with participants, focusing on findings specific to patients with brain/central nervous system (CNS) tumours.

All.Can international welcomes nomination of new EU Commissioner for Health and Food Safety

On 2 October 2019 All.Can international sent a letter to Stella Kyriakidou welcoming her unique perspective in the field of health, and sharing key findings from the All.Can patient survey.

All.Can welcomes Roche as a new funding member

All.Can is delighted to welcome Roche as a new funding member of the international initiative.

All.Can Australia launches national data from patient survey

All.Can Australia has launched the results of the national-level findings from the All.Can international patient survey. 

ICHOM–All.Can Improving Value in Cancer Care study discontinued

It is with great regret that All.Can has decided to discontinue the ICHOM–All.Can Improving Value in Cancer Care project.

All.Can Italy holds first public seminar on cancer networks

All.Can Italy held its first public seminar in Rome, bringing together patients, key opinion leaders and policymakers

International patient survey findings released in new report

Based on results of the All.Can patient survey, which was completed by almost 4,000 people affected by different cancers across 10 countries.

All.Can welcomes Baxter as a new contributor

All.Can is pleased to welcome Baxter as a new contributor to the international initiative.

All.Can at the ICHOM 2019 Conference

In May 2019 All.Can attended the International Consortium for Health Outcomes Measurement (ICHOM) Conference 2019, in Rotterdam.